Growth Metrics

RemSleep Holdings (RMSL) Operating Income Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 RemSleep Holdings - - -7,636.00 -23.71%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -23.71%
Sep 30, 2025 -1,076.25%
Jun 30, 2025 55.35%
Mar 31, 2025 -5.72%
Dec 31, 2024 83.14%
Sep 30, 2024 28.46%
Jun 30, 2024 -34.09%
Mar 31, 2024 43.79%
Dec 31, 2023 -156.68%
Sep 30, 2023 11.48%
Jun 30, 2023 35.76%
Mar 31, 2023 -42.97%
Dec 31, 2022 -260.05%
Sep 30, 2022 -274.41%
Jun 30, 2022 -155.13%
Mar 31, 2022 -63.96%
Dec 31, 2021 47.46%
Sep 30, 2021 -40.88%
Jun 30, 2021 -18.00%
Mar 31, 2021 -18.73%
Dec 31, 2020 -141.28%
Sep 30, 2020 48.32%
Jun 30, 2020 94.52%
Mar 31, 2020 -59.20%
Dec 31, 2019 -122.57%
Sep 30, 2019 53.72%
Jun 30, 2019 -580.60%
Mar 31, 2019 65.51%
Dec 31, 2018 570.29%
Sep 30, 2018 -122.03%
Jun 30, 2018 -7.96%
Mar 31, 2018 16.22%
Dec 31, 2017 49.14%
Sep 30, 2017 -45,301.66%
Jun 30, 2017 -8,703.62%
Mar 31, 2017 -557.28%
Dec 31, 2016 -1,151.63%
Sep 30, 2016 -4.78%
Jun 30, 2016 91.63%
Mar 31, 2016 23.13%
Dec 31, 2015 83.86%
Dec 31, 2014 30.85%
Dec 31, 2013 54.24%
Sep 30, 2013 57.07%
Jun 30, 2013 -23.56%
Mar 31, 2013 -1,095.58%
Dec 31, 2012 -1,055.05%
Jun 30, 2012 -845.45%
Mar 31, 2012 9.48%
Dec 31, 2011 99.98%